Literature summary extracted from
Shannon, A.; Selisko, B.; Le, N.T.; Huchting, J.; Touret, F.; Piorkowski, G.; Fattorini, V.; Ferron, F.; Decroly, E.; Meier, C.; Coutard, B.; Peersen, O.; Canard, B.
Rapid incorporation of Favipiravir by the fast and permissive viral RNA polymerase complex results in SARS-CoV-2 lethal mutagenesis (2020), Nat. Commun., 11, 4682 .
Cloned(Commentary)
EC Number |
Cloned (Comment) |
Organism |
---|
2.7.7.48 |
expression in Escherichia coli |
Severe acute respiratory syndrome coronavirus 2 |
Inhibitors
EC Number |
Inhibitors |
Comment |
Organism |
Structure |
---|
2.7.7.48 |
favipiravir |
unusually high nucleotide incorporation rates and high error rates of SARS-CoV RNA-dependent-RNA-polymerase allow facile insertion of Favipiravir into viral RNA, provoking C-to-U and G-to-A transitions in the already low cytosine content SARS-CoV-2 genome |
Severe acute respiratory syndrome coronavirus 2 |
|
Localization
EC Number |
Localization |
Comment |
Organism |
GeneOntology No. |
Textmining |
---|
Natural Substrates/ Products (Substrates)
EC Number |
Natural Substrates |
Organism |
Comment (Nat. Sub.) |
Natural Products |
Comment (Nat. Pro.) |
Rev. |
Reac. |
---|
2.7.7.48 |
nucleoside triphosphate + RNAn |
Severe acute respiratory syndrome coronavirus 2 |
- |
diphosphate + RNAn+1 |
- |
? |
|
Organism
EC Number |
Organism |
UniProt |
Comment |
Textmining |
---|
2.7.7.48 |
Severe acute respiratory syndrome coronavirus 2 |
P0DTD1 |
replicase polyprotein 1ab; SARS-CoV-2 |
- |
Substrates and Products (Substrate)
EC Number |
Substrates |
Comment Substrates |
Organism |
Products |
Comment (Products) |
Rev. |
Reac. |
---|
2.7.7.48 |
nucleoside triphosphate + RNAn |
- |
Severe acute respiratory syndrome coronavirus 2 |
diphosphate + RNAn+1 |
- |
? |
|
Synonyms
EC Number |
Synonyms |
Comment |
Organism |
---|
2.7.7.48 |
RDRP |
- |
Severe acute respiratory syndrome coronavirus 2 |
2.7.7.48 |
RNA-dependent RNA polymerase |
- |
Severe acute respiratory syndrome coronavirus 2 |
General Information
EC Number |
General Information |
Comment |
Organism |
---|
2.7.7.48 |
drug target |
the viral RNA-dependent-RNA-polymerase (RdRp) is a target with polymerase inhibitors successfully used for the treatment of several viral diseases |
Severe acute respiratory syndrome coronavirus 2 |